Severe pancreatitis with exocrine destruction and increased islet neogenesis in mice with suppressor of cytokine signaling-1 deficiency

被引:26
作者
Chen, Y
Chong, MMW
Darwiche, R
Thomas, HE
Kay, TWH
机构
[1] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[2] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3065, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0002-9440(10)63353-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mice with suppressor of cytokine signaling-1 (SOCS-1) deficiency die within 3 weeks of birth from a multiorgan inflammatory disease. Increased systemic levels and sensitivity of cells to the inflammatory cytokines interferon-gamma and tumor necrosis factor may contribute to the disease. Hepatitis and liver failure are thought to be the cause of die neonatal lethality in these mice. Here, we show that die pancreata of SOCS-1(-/-) mice are also severely affected by inflammation, displaying extensive edema and infiltration by T cells and macrophages. Acinar cells in particular were atrophied and reduced in their zymogen content The expression of inflammatory markers, including class I major histocompatibility complex and inducible nitric oxide synthase, were increased in the SOCS-1(-/-) pancreas. Although there was generalized up-regulation of class I major histocompatibility complex, inducible nitric oxide synthase expression was more prominent on exocrine tissues. There appeared to be preferential damage and apoptosis of exocrine over endocrine components. Unexpectedly, increased islet neogenesis, possibly from proliferating ductal cells, was observed in the pancreas of SOCS-1(-/-) mice. This is reminiscent of the pancreatitis and islet neogenesis that occur in mice that transgenically overexpress; interferon-gamma and/or tumor necrosis factor. This study suggests that in addition to liver failure, the pancreatitis may also be an important contributor to the neonatal lethality in SOCS-1(-/-) mice.
引用
收藏
页码:913 / 921
页数:9
相关论文
共 50 条
  • [1] SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
    Alexander, WS
    Starr, R
    Fenner, JE
    Scott, GL
    Handman, E
    Sprigg, NS
    Corbin, JE
    Cornish, AL
    Darwiche, R
    Owczarek, CM
    Kay, TWH
    Nicola, NA
    Hertzog, PJ
    Metcalf, D
    Hilton, DJ
    [J]. CELL, 1999, 98 (05) : 597 - 608
  • [2] ORIGIN OF TUBULAR COMPLEXES IN HUMAN CHRONIC-PANCREATITIS
    BOCKMAN, DE
    BOYDSTON, WR
    ANDERSON, MC
    [J]. AMERICAN JOURNAL OF SURGERY, 1982, 144 (02) : 243 - 249
  • [3] Bockman DE, 1997, MICROSC RES TECHNIQ, V37, P509, DOI 10.1002/(SICI)1097-0029(19970601)37:5/6<509::AID-JEMT13>3.0.CO
  • [4] 2-U
  • [5] Suppressor of cytokine signaling-1 attenuates the duration of interferon γ signal transduction in vitro and in vivo
    Brysha, M
    Zhang, JG
    Bertolino, P
    Corbin, JE
    Alexander, WS
    Nicola, NA
    Hilton, DJ
    Starr, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (25) : 22086 - 22089
  • [6] REDUCTION IN INSULITIS FOLLOWING ADMINISTRATION OF IFN-GAMMA AND TNF-ALPHA IN THE NOD MOUSE
    CAMPBELL, IL
    OXBROW, L
    HARRISON, LC
    [J]. JOURNAL OF AUTOIMMUNITY, 1991, 4 (02) : 249 - 262
  • [7] INTERFERON-GAMMA ENHANCES THE EXPRESSION OF THE MAJOR HISTOCOMPATIBILITY CLASS-I ANTIGENS ON MOUSE PANCREATIC BETA-CELLS
    CAMPBELL, IL
    WONG, GHW
    SCHRADER, JW
    HARRISON, LC
    [J]. DIABETES, 1985, 34 (11) : 1205 - 1209
  • [8] γ-interferon signaling in pancreatic β-cells is persistent but can be terminated by overexpression of suppressor of cytokine signaling-1
    Chong, MMW
    Thomas, HE
    Kay, TWH
    [J]. DIABETES, 2001, 50 (12) : 2744 - 2751
  • [9] Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic β cells to tumor necrosis factor
    Chong, MMW
    Thomas, HE
    Kay, TWH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) : 27945 - 27952
  • [10] INTRAISLET RELEASE OF INTERLEUKIN-1 INHIBITS BETA-CELL FUNCTION BY INDUCING BETA-CELL EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE
    CORBETT, JA
    MCDANIEL, ML
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) : 559 - 568